Vimarsana
Biggest News Aggregation in the World

Neuromuscular Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuromuscular Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuromuscular Program Today - Breaking & Trending Today

WUSA Wusa 9 News At 5pm July 31, 2014 - Vimarsana News

WUSA Wusa 9 News At 5pm July 31, 2014

Is coming across as a reluctant santa claus. The prosecution is walking him through every gift request of the mcdonnells and for most of them he comes through and, in fact, today the jury got to hold and touch one of the most talked about gifts, that rolex watch. Jonnie williams admitted on the stand today that he knew what he was doing was wrong, maybe illegal. He lavished mcdonnells with expense gifts, 120,000 in loans, golf outings, stays in his vacation home, a new york shopping spree, use of his ferrari. He said he gave the gifts to get the governors help in securing state funded studies ...

WUSA Wusa 9 News At 11pm July 31, 2014 - Vimarsana News

WUSA Wusa 9 News At 11pm July 31, 2014

Mcguinty. And im lesli foster. Tonight in d. C. The names of those killed were read one by one in front of the white house, the Obama Administration condemning a deadly shelling of a United Nations school crowded with refugees. Israel said they were targeted by an area of rounds that launched from the school and they fired back. Israeli strikes also hit a crowded shopping area in gaza city. The u. N. Calls that unjustifiable. Tonight a d. C. Based jewish group is expressing outrage over comments made by a congressional leader concerning hamas. Kgw reporter jim osmond tells us about a statement...

REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial - Vimarsana News

REGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trial

Company to host webcast on Tuesday, March 5, 2024 at 8:30 a.m. ESTInterim clinical data will be presented by Aravindhan Veerapandiyan, M.D., primary investigator of the AFFINITY DUCHENNE trial, at...

Parent Project Muscular Dystrophy Provides $250,000 in Funding to Rare Disease Research, LLC to Establish New Clinical Trial Site - Vimarsana News

Parent Project Muscular Dystrophy Provides $250,000 in Funding to Rare Disease Research, LLC to Establish New Clinical Trial Site

/PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today...

REGENXBIO Announces Phase I/II Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy, is Active and Recruiting Patients - Vimarsana News

REGENXBIO Announces Phase I/II Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy, is Active and Recruiting Patients

- Company has initiated Phase I/II AFFINITY DUCHENNE™ trial of RGX-202 - Company also enrolling newly active observational screening study, AFFINITY BEYOND,...